Symbols / UPC Stock $3.00 -8.54% Universe Pharmaceuticals INC

Healthcare • Drug Manufacturers - Specialty & Generic • China • NCM
UPC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Gang Lai
Exch · Country NCM · China
Market Cap 1.69M
Enterprise Value -22.49M
Income -3.67M
Sales 17.86M
FCF (ttm) -10.24M
Book/sh 99.64
Cash/sh 59.63
Employees 216
Insider 10d —
IPO Mar 23, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S 0.09
P/B 0.03
P/C —
EV/EBITDA 9.38
EV/Sales -1.26
Quick Ratio 3.55
Current Ratio 4.07
Debt/Eq 16.49
LT Debt/Eq —
EPS (ttm) -8.06
EPS next Y —
EPS Growth —
Revenue Growth -14.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -2.66%
ROE -7.23%
ROIC —
Gross Margin 35.28%
Oper. Margin -6.77%
Profit Margin -20.56%
Shs Outstand 563.34K
Shs Float 559.87K
Insider Own 0.62%
Instit Own 5.19%
Short Float 0.82%
Short Ratio 1.03
Short Interest 4.61K
52W High 11.00
vs 52W High -72.73%
52W Low 2.00
vs 52W Low 50.00%
Beta 1.48
Impl. Vol. —
Rel Volume 0.26
Avg Volume 9.04K
Volume 2.38K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $3.28
Price $3.00
Change -8.54%
About

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$3.05
Latest analyst target
3. DCF / Fair value
$-327.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.05
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
17.86
-22.44%
23.02
-28.74%
32.31
-19.52%
40.14
Operating Revenue
17.86
-22.44%
23.02
-28.74%
32.31
-19.52%
40.14
Cost Of Revenue
11.56
-31.82%
16.95
-22.92%
21.99
+20.50%
18.25
Reconciled Cost Of Revenue
11.29
-32.32%
16.68
-23.08%
21.68
+21.10%
17.90
Gross Profit
6.30
+3.78%
6.07
-41.14%
10.32
-52.88%
21.89
Operating Expense
9.22
-34.59%
14.09
-1.33%
14.28
-50.60%
28.91
Research And Development
0.67
-81.33%
3.60
-25.94%
4.86
-36.44%
7.64
Selling General And Administration
8.00
-18.98%
9.88
+9.73%
9.00
-56.80%
20.84
Selling And Marketing Expense
3.80
-43.24%
6.69
+11.36%
6.01
-67.19%
18.30
General And Administrative Expense
4.21
+31.89%
3.19
+6.47%
3.00
+18.32%
2.53
Salaries And Wages
1.65
+0.11%
1.65
+9.21%
1.51
+6.08%
1.42
Other Gand A
2.56
+65.75%
1.54
+3.71%
1.49
+33.95%
1.11
Other Operating Expenses
0.02
-37.90%
0.03
-38.83%
0.05
+19.21%
0.04
Total Expenses
20.77
-33.08%
31.04
-14.42%
36.27
-23.09%
47.16
Operating Income
-2.92
+63.64%
-8.02
-102.21%
-3.97
+43.50%
-7.02
Total Operating Income As Reported
-2.92
+63.64%
-8.02
-102.21%
-3.97
+43.50%
-7.02
EBITDA
-2.92
+60.27%
-7.36
-100.90%
-3.66
+42.77%
-6.40
Normalized EBITDA
-2.44
+66.81%
-7.36
-100.90%
-3.66
+42.77%
-6.40
Reconciled Depreciation
0.52
+6.53%
0.49
-4.53%
0.51
-4.71%
0.53
EBIT
-3.44
+56.14%
-7.84
-88.04%
-4.17
+39.83%
-6.93
Total Unusual Items
-0.48
0.00
0.00
+100.00%
-0.47
Total Unusual Items Excluding Goodwill
-0.48
0.00
0.00
+100.00%
-0.47
Special Income Charges
-0.48
0.00
0.00
+100.00%
-0.42
Impairment Of Capital Assets
0.48
0.00
0.00
—
Write Off
—
—
-0.44
-204.76%
0.42
Net Income
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Pretax Income
-3.67
+54.78%
-8.12
-87.65%
-4.33
+39.00%
-7.09
Net Non Operating Interest Income Expense
-0.23
+16.58%
-0.28
-77.42%
-0.16
+3.46%
-0.16
Interest Expense Non Operating
0.23
-16.58%
0.28
+77.42%
0.16
-3.46%
0.16
Net Interest Income
-0.23
+16.58%
-0.28
-77.42%
-0.16
+3.46%
-0.16
Interest Expense
0.23
-16.58%
0.28
+77.42%
0.16
-3.46%
0.16
Other Income Expense
-0.52
-395.40%
0.18
+186.74%
-0.20
-333.69%
0.09
Other Non Operating Income Expenses
-0.11
-174.27%
0.15
+161.74%
-0.24
-581.43%
0.05
Gain On Sale Of Security
—
—
0.04
+108.19%
-0.47
Tax Provision
0.00
-100.00%
0.61
-73.08%
2.25
+176.41%
0.82
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Net Income From Continuing Operation Net Minority Interest
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Net Income From Continuing And Discontinued Operation
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Net Income Continuous Operations
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Normalized Income
-3.19
+63.44%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Net Income Common Stockholders
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Diluted EPS
—
-626.96
+42.44%
-1,089.21
+18.43%
-1,335.29
Basic EPS
—
-626.96
+42.44%
-1,089.21
+18.43%
-1,335.29
Basic Average Shares
—
0.01
+130.39%
0.01
+2.01%
0.01
Diluted Average Shares
—
0.01
+130.39%
0.01
+2.01%
0.01
Diluted NI Availto Com Stockholders
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Depreciation Amortization Depletion Income Statement
0.25
+17.52%
0.21
+7.24%
0.20
+5.55%
0.19
Depreciation And Amortization In Income Statement
0.25
+17.52%
0.21
+7.24%
0.20
+5.55%
0.19
Earnings From Equity Interest
0.07
+103.68%
0.03
+2.80%
0.03
-19.48%
0.04
Other Taxes
0.39
+59.27%
0.25
+37.42%
0.18
-12.84%
0.21
Provision For Doubtful Accounts
-0.11
-186.22%
0.13
0.00
-100.00%
0.42
Line Item Trend 2023-09-30
Total Assets
41.72
Current Assets
25.27
Cash Cash Equivalents And Short Term Investments
5.29
Cash And Cash Equivalents
5.29
Cash Financial
5.29
Other Short Term Investments
13.22
Receivables
12.52
Accounts Receivable
11.01
Gross Accounts Receivable
11.01
Allowance For Doubtful Accounts Receivable
0.00
Other Receivables
1.44
Inventory
3.34
Raw Materials
0.64
Finished Goods
2.78
Prepaid Assets
4.09
Current Deferred Assets
—
Other Current Assets
0.04
Total Non Current Assets
16.45
Net PPE
14.99
Gross PPE
21.04
Accumulated Depreciation
-6.05
Properties
0.00
Buildings And Improvements
7.30
Machinery Furniture Equipment
2.45
Construction In Progress
11.29
Goodwill And Other Intangible Assets
0.15
Other Intangible Assets
0.15
Investments And Advances
0.69
Non Current Deferred Assets
0.60
Non Current Deferred Taxes Assets
0.60
Non Current Prepaid Assets
0.04
Total Liabilities Net Minority Interest
13.75
Current Liabilities
13.75
Payables And Accrued Expenses
8.27
Payables
5.56
Accounts Payable
4.59
Other Payable
—
Current Accrued Expenses
2.71
Total Tax Payable
0.43
Income Tax Payable
—
Current Debt And Capital Lease Obligation
5.48
Current Debt
5.48
Other Current Borrowings
5.48
Current Deferred Liabilities
—
Current Deferred Revenue
—
Total Non Current Liabilities Net Minority Interest
0.00
Long Term Debt And Capital Lease Obligation
—
Long Term Debt
—
Stockholders Equity
27.97
Common Stock Equity
27.97
Capital Stock
0.07
Common Stock
0.07
Share Issued
0.01
Ordinary Shares Number
0.01
Treasury Shares Number
0.00
Additional Paid In Capital
29.28
Retained Earnings
-1.44
Gains Losses Not Affecting Retained Earnings
0.07
Other Equity Adjustments
0.07
Total Equity Gross Minority Interest
27.97
Total Capitalization
27.97
Working Capital
11.52
Invested Capital
33.45
Total Debt
5.48
Net Debt
0.20
Net Tangible Assets
27.82
Tangible Book Value
27.82
Available For Sale Securities
0.69
Duefrom Related Parties Current
0.06
Dueto Related Parties Current
0.54
Inventories Adjustments Allowances
-0.07
Investmentin Financial Assets
0.69
Line Of Credit
5.48
Other Inventories
—
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-5.05
+46.86%
-9.51
-951.26%
1.12
+185.80%
-1.30
Cash Flow From Continuing Operating Activities
-5.05
+46.86%
-9.51
-951.26%
1.12
+185.80%
-1.30
Net Income From Continuing Operations
-3.67
+57.92%
-8.73
-32.61%
-6.58
+16.80%
-7.91
Depreciation Amortization Depletion
0.52
+6.53%
0.49
-4.53%
0.51
-4.71%
0.53
Depreciation And Amortization
0.52
+6.53%
0.49
-4.53%
0.51
-4.71%
0.53
Provisionand Write Offof Assets
-0.11
-162.26%
0.18
+470.65%
-0.05
-411.69%
0.02
Asset Impairment Charge
0.48
0.00
0.00
—
Deferred Tax
0.00
-100.00%
0.61
-61.30%
1.57
+389.04%
-0.54
Deferred Income Tax
0.00
-100.00%
0.61
-61.30%
1.57
+389.04%
-0.54
Operating Gains Losses
0.00
-25.52%
0.00
+3371.93%
0.00
-88.40%
0.00
Gain Loss On Investment Securities
—
—
-0.04
-108.19%
0.47
Gain Loss On Sale Of PPE
0.00
-25.52%
0.00
+3371.93%
0.00
-88.40%
0.00
Change In Working Capital
-2.27
-10.22%
-2.06
-136.29%
5.67
-14.08%
6.60
Change In Receivables
3.13
+283.52%
-1.71
-133.38%
5.11
+299.88%
-2.56
Changes In Account Receivables
-0.17
+89.08%
-1.55
-132.81%
4.72
+409.13%
-1.53
Change In Inventory
-0.47
-128.89%
1.64
+238.80%
-1.18
-7237.48%
0.02
Change In Prepaid Assets
-0.72
+53.11%
-1.53
-390.09%
0.53
-94.54%
9.64
Change In Payables And Accrued Expense
-4.25
-805.85%
-0.47
-121.65%
2.17
+528.69%
-0.51
Change In Accrued Expense
-0.09
-171.52%
-0.03
-118.50%
0.17
-92.67%
2.32
Change In Payable
-4.16
-851.47%
-0.44
-121.92%
2.00
+170.70%
-2.82
Change In Account Payable
-3.13
-2279.32%
0.14
-91.24%
1.64
+185.50%
-1.92
Change In Other Working Capital
0.04
—
-0.95
—
Investing Cash Flow
-0.34
+5.39%
-0.36
-717.96%
-0.04
+98.87%
-3.91
Cash Flow From Continuing Investing Activities
-0.34
+5.39%
-0.36
-717.96%
-0.04
+98.87%
-3.91
Net PPE Purchase And Sale
-0.26
-7.13%
-0.24
-452.41%
-0.04
+52.60%
-0.09
Purchase Of PPE
-0.27
-8.53%
-0.25
-456.49%
-0.04
+52.86%
-0.09
Sale Of PPE
0.01
+198.23%
0.00
0.00
-100.00%
0.00
Capital Expenditure
-0.35
+4.38%
-0.36
-722.04%
-0.04
+52.86%
-0.09
Net Investment Purchase And Sale
—
—
0.00
0.00
Purchase Of Investment
—
—
0.00
0.00
Sale Of Investment
—
—
0.00
0.00
Net Business Purchase And Sale
—
0.00
0.00
+100.00%
-3.81
Purchase Of Business
—
0.00
0.00
+100.00%
-3.81
Net Intangibles Purchase And Sale
-0.08
+31.44%
-0.12
0.00
0.00
Purchase Of Intangibles
-0.08
+31.44%
-0.12
0.00
0.00
Financing Cash Flow
9.73
-71.36%
33.95
+2541.62%
-1.39
-141.91%
3.32
Cash Flow From Continuing Financing Activities
9.73
-71.36%
33.95
+2541.62%
-1.39
-141.91%
3.32
Net Issuance Payments Of Debt
-5.27
-158.90%
8.95
+743.90%
-1.39
-141.91%
3.32
Issuance Of Debt
10.27
-40.69%
17.32
+88.08%
9.21
+21.30%
7.59
Repayment Of Debt
-15.54
-85.87%
-8.36
+21.09%
-10.60
-148.04%
-4.27
Long Term Debt Issuance
10.27
-40.69%
17.32
+88.08%
9.21
+21.30%
7.59
Long Term Debt Payments
-15.54
-85.87%
-8.36
+21.09%
-10.60
-148.04%
-4.27
Net Long Term Debt Issuance
-5.27
-158.90%
8.95
+743.90%
-1.39
-141.91%
3.32
Short Term Debt Issuance
—
—
5.67
+32.73%
4.27
Short Term Debt Payments
—
—
-3.97
+7.09%
-4.27
Net Short Term Debt Issuance
—
—
1.70
0.00
Net Common Stock Issuance
15.00
-40.00%
25.00
0.00
0.00
Common Stock Dividend Paid
—
—
—
0.00
Cash Dividends Paid
—
—
—
0.00
Net Other Financing Charges
—
—
-3.09
-193.19%
3.32
Changes In Cash
4.33
-82.01%
24.09
+7673.37%
-0.32
+83.19%
-1.89
Effect Of Exchange Rate Changes
-0.24
-288.50%
0.13
+216.56%
-0.11
+77.21%
-0.47
Beginning Cash Position
29.50
+458.11%
5.29
-7.46%
5.71
-29.30%
8.08
End Cash Position
33.59
+13.88%
29.50
+458.11%
5.29
-7.46%
5.71
Free Cash Flow
-5.40
+45.29%
-9.87
-1020.17%
1.07
+176.88%
-1.40
Interest Paid Supplemental Data
0.29
-4.97%
0.30
+60.12%
0.19
-4.84%
0.20
Income Tax Paid Supplemental Data
0.00
0.00
-100.00%
0.86
-68.57%
2.75
Change In Income Tax Payable
-0.32
-158.53%
0.55
+97.35%
0.28
+131.07%
-0.90
Change In Tax Payable
-0.32
-158.53%
0.55
+97.35%
0.28
+131.07%
-0.90
Common Stock Issuance
15.00
-40.00%
25.00
0.00
0.00
Issuance Of Capital Stock
15.00
-40.00%
25.00
0.00
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category